Asan Medical Center

33 results found.

Leukemia, Myeloid Clinical Trial using autologous hematopoietic cell transplantation

Asan Medical Center - Recruiting 15 years to 65 years.
- Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission.
autologous hematopoietic cell transplantation

Coronary Restenosis Clinical Trial using Everolimus-eluting balloon expandable stent; paclitaxel eluting balloon

Asan Medical Center - Recruiting 20 years or older.
- Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis.
Everolimus-eluting balloon expandable stent; paclitaxel eluting balloon

Coronary Artery Disease, or Angioplasty, Balloon Clinical Trial using Balloon angioplasty

Asan Medical Center - Recruiting 20 years or older.
- Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study.
Balloon angioplasty

Advanced Gastric Cancer Clinical Trial using Docetaxel, Capecitabine, Cisplatin, Bevacizumab

Asan Medical Center - Recruiting 18 years to 70 years.
- A Phase II Study of Neoadjuvant Chemotherapy With Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer.
Docetaxel, Capecitabine, Cisplatin, Bevacizumab

Interstitial Cystitis Clinical Trial

Asan Medical Center - Recruiting 20 years or older.
- Experimental Study of Biomarker in Patient With Interstitial Cystitis/Painful Bladder.

Leukemia, Acute Lymphoblastic, Precursor B-Cell Lymphoblastic Leu Clinical Trial using Diagnosed as ALL

Asan Medical Center - Recruiting 15 years or older.
- Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center.
Diagnosed as ALL

Hepatocellular Carcinoma Clinical Trial using TACE+EBRT; Sorafenib

Asan Medical Center - Recruiting 20 years or older.
- Randomized Phase II Trial Comparing Transarterial Chemoembolization Plus External Beam Radiotherapy Versus Sorafenib in Patients With Hepatocellular Carcinoma With Major Vascular Invasion.
TACE+EBRT; Sorafenib

Hemophagocytic Lymphohistiocytosis Clinical Trial using IST and/or alloHCT

Asan Medical Center - Recruiting 18 years to 80 years.
- Pilot Study of First-line Immunosuppressive Therapy Combined With Etoposide and Allogeneic Hematopoietic Cell Transplantation in Refractory/Reactivated Cases for Hemophagocytic Lymphohistiocytosis (HLH) in Adult Patients.
IST and/or alloHCT

Interstitial Cystitis Clinical Trial using Hyaluronic acid/chondroitin sulfate

Asan Medical Center - Recruiting 20 years or older.
- The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome..
Hyaluronic acid/chondroitin sulfate

IPMN Clinical Trial

Asan Medical Center - Recruiting 20 years or older.
- Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012.

Metastatic or Recurrent Gastric Adenocarcinoma, or Her-2 Positive Clinical Trial using Herceptin+XELOX

Asan Medical Center - Recruiting 20 years or older.
- A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer.
Herceptin+XELOX

Gastrointestinal Stromal Tumors Clinical Trial using imatinib

Asan Medical Center - Recruiting 18 years or older.
- A Phase II Study of Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation.
imatinib

Gastric Cancer Clinical Trial using Dovitinib

Asan Medical Center - Recruiting 18 years or older.
- A Phase II Trial of Dovitinib Monotherapy as Salvage Treatment in Patients With Metastatic or Unresectable Gastric Cancer Harboring FGFR2(Fibroblast Growth Factor Receptor 2) Amplification After Failure of First or Second Line Chemotherapy.
Dovitinib

Cervical Cancer Clinical Trial using Sonifilan

Asan Medical Center - Recruiting 20 years to 75 years.
- The Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer.
Sonifilan

Invasive Fungal Infection Clinical Trial using voriconazole

Asan Medical Center - Recruiting 15 years or older.
- The Correlation of Voriconazole Trough Plasma Levels With Genetic Polymorphism, Efficacy, and Safety Outcomes in Hematologic Malignancy Patients With Invasive Pulmonary Aspergillosis.
voriconazole

Kidney Transplantation Clinical Trial using routine dose tacrolimus and myfortic; low dose tacrolimus and myfortic

Asan Medical Center - Recruiting 20 years to 65 years.
- Organ Function Preservation by the Combination Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients: OPTIMUM Study.
routine dose tacrolimus and myfortic; low dose tacrolimus and myfortic

Renal Insufficiency, Kidney Diseases, or Urologic Diseases Clinical Trial using Mirodenafil

Asan Medical Center - Recruiting 19 years to 64 years.
- Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients.
Mirodenafil

Precursor Cell Lymphoblastic Leukemia-Lymphoma Clinical Trial using Rituximab+mVPDL

Asan Medical Center - Recruiting 15 years or older.
- Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Philadelphia-Negative Adult Acute Lymphoblastic Leukemia.
Rituximab+mVPDL

Acute Leukemia, Myelodysplastic Syndrome, or Solid Tumors Clinical Trial using anti-thymocyte globulin; filgrastim; Total body irradiation; Fludarabine; cyclophosphamide; Tacrolimus; Mycophenolate mofetil; Rituximab

Asan Medical Center - Recruiting N/A to 21 years.
- HLA-haploidentical Allogeneic Hematopoietic Cell Transplantation Using CD3 Depletion for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors After Conditioning of TBI, Fludarabine, Cyclophosphamide and Antithymocyte Globulin.
anti-thymocyte globulin; filgrastim; Total body irradiation; Fludarabine; cyclophosphamide; Tacrolimus; Mycophenolate mofetil; Rituximab

Non-small Cell Lung Cancer Clinical Trial using Gefitinib

Asan Medical Center - Recruiting 19 years or older.
- First Line Gefitinib Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) by the FDG-PET Metabolic Response.
Gefitinib

Rectal Cancer, or Liver Metastases Clinical Trial using Capecitabine, Oxaliplatin; Radiotherapy

Asan Medical Center - Recruiting 20 years to 75 years.
- Randomized Phase II Trial of Preoperative Chemoradiation With or Without Induction Chemotherapy In Patients With Locally Advanced Or Borderlinely Resectable Rectal Cancer With Resectable Synchronous Liver Metastases.
Capecitabine, Oxaliplatin; Radiotherapy

Benign Uterine Disease Clinical Trial

Asan Medical Center - Recruiting 20 years to 80 years.
- Incidence and Pattern of Overactive Bladder Symptoms Occurring After Hysterectomy.

Colorectal Neoplasms Clinical Trial using Optimized ESD with snaring; Conventional ESD

Asan Medical Center - Recruiting 18 years or older.
- Comparison of Coventional Endoscopic Submucosal Dissection and Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm.
Optimized ESD with snaring; Conventional ESD

Central Serous Chorioretinopathy Clinical Trial using Intravitreal Aflibercept injection; Sham injection; Half-fluence photodynamic therapy

Asan Medical Center - Recruiting 18 years to 60 years.
- Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy.
Intravitreal Aflibercept injection; Sham injection; Half-fluence photodynamic therapy

Brain Ischemia Clinical Trial using Aggressive BP lowering; modest blood pressure lowering

Asan Medical Center - Recruiting 40 years or older.
- Multicenter Clinical Trial for Development of Guidelines of Adequate Blood Pressure Lowering in the Subacute Ischemic Stroke Patients Due to Intracranial Atherosclerosis.
Aggressive BP lowering; modest blood pressure lowering

Polyp of Large Intestine Clinical Trial using prophylactic clip application

Asan Medical Center - Recruiting 20 years or older.
- Does a Prophylactic Clip Application Decrease IPPB(Immediate Postpolypectomy Bleeding) and DPPB(Delayed Postpolypectomy Bleeding) After Colonoscopic Removal for a Large Pedunculated Polyps (>1cm)?.
prophylactic clip application

Breast Cancer Clinical Trial using Adriamycin+Cyclophosphamide>Docetaxel; GnRHa with Tamoxifen

Asan Medical Center - Recruiting 20 years or older.
- A Phase III, Open-Label, Prospective, Randomized, Multicenter, Neo-adjuvant Study of Chemotherapy Versus Endocrine Therapy in Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer.
Adriamycin+Cyclophosphamide>Docetaxel; GnRHa with Tamoxifen

Liver Cirrhosis, or Carcinoma, Hepatocellular Clinical Trial

Asan Medical Center - Recruiting 20 years to 80 years.
- Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver: Prospective Pathologic Correlation With Explanted Liver.

Cystic Tumors of the Pancreas Clinical Trial using Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection

Asan Medical Center - Recruiting 20 years to 85 years.
- Phase 2/3 Study of EUS-guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas.
Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection

Severe Pneumonia Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients.

Kidney Transplantation Recipients Clinical Trial

Asan Medical Center - Recruiting 16 years to 90 years.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients (ACE-KT).

Kidney Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT).

Bone Marrow Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT).